Therapeutic Goods Administration
Australia's regulatory authority for therapeutic goods. More about the TGA...
New to this website? You might like to start here:
Consumers
Do you use or buy therapeutic goods for your own use or for someone else?
Do you use or buy therapeutic goods for your own use or for someone else?
Do you use or buy therapeutic goods for your own use or for someone else?
Do you use or buy therapeutic goods for your own use or for someone else?
Latest news & updatesNews
23 May 2012
RASML updates 5 & 6: Submissions & TGA response to submissions
Version 3.0
23 May 2012
Information about weight loss product 'Undoit'
The sponsor of the product Undoit AUST L 193428 has cancelled the product's listing on the Australian Register of Therapeutic Goods
18 May 2012
PIP breast implants - TGA update
Updated information on safety concerns with PIP breast implants
18 May 2012
Quad (4 X Point) Walking Stick
Medical device recall notice
PIP implants
Featured
Counterfeit products
Counterfeit medicines or medical devices are often packaged or marketed to mimic a genuine item.
Seasonal influenza vaccines
2012 seasonal influenza vaccines for use in children
TGA reforms: a blueprint for TGA's future
The Australian Government has released its response to several major reviews of therapeutic goods regulation
The regulation of medical devices
Medical devices range from sticking plasters that would be put on a scratch, to high-risk products such as pacemakers that are implanted in the body
Complementary medicines
An overview of the regulatory framework for complementary medicines
Buying online
The Internet can offer consumers a convenient way to access therapeutic goods, but online purchases of medicines or devices should be approached with caution.
Evaluation of a new medicine - The TGA's lifecycle approach to regulation
The TGA aims to ensure that the community has access to therapeutic advances within a reasonable timeframe
Australian Public Assessment Reports for prescription medicines (AusPARs)
An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application